Disease/Infection News

RSS

Multi-country study of severe pneumonia in hospitalized children

The Johns Hopkins Bloomberg School of Public Health announced on Tuesday the launch of "a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study … a large multi-country case-control study of severe pneumonia in hospitalized children under five years of age … being conducted in Bangladesh, The Gambia, Kenya, Mali, South Africa, Thailand, and Zambia," according to a JHSPH press release.

18 Aug 2011

World must invest equally in bird flu prevention and response

The "reports during the past two weeks of two recent infections and another death" from H5N1 (avian) influenza "raised little concern except among public health officials," Robert Gatter, co-director of the Center for Health Law Studies and professor of law at Saint Louis University, writes in an Atlanta Journal-Constitution opinion piece, adding that "the fact that bird flu in developing nations receives little public attention reveals that the world has become complacent about this threat."

18 Aug 2011

New collaboration for development of new malaria vaccine

"The Infectious Disease Research Institute (IDRI) today announced a new Memorandum of Understanding with the United States Agency for International Development (USAID), focused on support of a collaboration with the Walter Reed Army Institute of Research (WRAIR) for the development of a new vaccine against malaria," an IDRI press release states.

18 Aug 2011

DNDi addresses 'alarming lack' of R&D for neglected diseases

In a Center for Global Health R&D Policy Assessment blog post, the third part of the center's Product Development Partnership (PDP) mini-series, "Bernard Pecoul from the Drugs for Neglected Diseases initiative (DNDi) discusses their experience with partnerships to develop treatments for neglected diseases."

18 Aug 2011

Researchers isolate 17 novel antibodies against HIV

A team of researchers at and associated with the International AIDS Vaccine Initiative (IAVI), The Scripps Research Institute, the biotechnology company Theraclone Sciences and Monogram Biosciences Inc., a LabCorp company, report in the current issue of Nature the isolation of 17 novel antibodies capable of neutralizing a broad spectrum of variants of HIV, the virus that causes AIDS.

18 Aug 2011

GeoVax receives NIH-NIAID grant for HIV/AIDS vaccine program

GeoVax Labs, Inc., an Atlanta-based, biopharmaceutical firm developing vaccines to prevent and fight Human Immunodeficiency Virus (HIV) infections, today announced receipt of a $3.6 million annual notice of award for the Integrated Preclinical/Clinical AIDS Vaccine Development (IPCAVD) Grant supporting GeoVax's HIV/AIDS vaccine program.

17 Aug 2011

Washington Post examines history, future of mosquito control efforts

The Washington Post looks at the history and future of disease-carrying mosquitoes, "the most deadly non-human animal on the planet." The newspaper describes several mosquito-control methods, and poses the question, "If scientists could find a way to wipe out all mosquitoes - recent studies have shown that it may be possible to chemically sterilize males and dupe the females into mating with them - would that be a good idea?".

17 Aug 2011

PERCH study to look at current and likely future causes of childhood pneumonia

Pneumonia kills more children around the world than any other disease, but the last major effort to study the causes of childhood pneumonia across many countries was conducted in the 1980's. This week, a groundbreaking new study called the Pneumonia Etiology Research for Child Health (PERCH) study gets off the ground.

17 Aug 2011

Emotions hinder disease eradication

In a New York Times essay, journalist Donald McNeil writes, "To a doctor, all epidemics are objectively different … But to the mortals they mow down, all epidemics are emotionally alike — an onslaught of fear, awe, repulsion, stigma, denial, rage and blame — and doctors would be foolish to forget that."

17 Aug 2011

Bayer Healthcare to provide over 600,000 moxifloxacin tablets to fight MDR-TB in China

Bayer Healthcare announced on Monday it "has agreed to support the World Health Organization (WHO) and the Stop TB Partnership in the fight against multidrug-resistant tuberculosis (MDR-TB) by making 620,000 tablets of the antibiotic moxifloxacin available to WHO," according to a Bayer press release.

17 Aug 2011

Methodist, Philips partner to develop new imaging technology for infectious diseases

The Methodist Hospital Research Institute and Philips Healthcare are collaborating to develop new imaging technology that could be used to help identify the start -- and cause -- of an infectious disease epidemic.

From Philips Healthcare 17 Aug 2011

Global AIDS funding in 2010 down nearly 10% from previous year, Kaiser/UNAIDS report says

"Spending on the global fight against AIDS fell significantly in 2010 for the first time since the U.S. and other governments began making major donations," according to an annual funding analysis released Monday by the Kaiser Family Foundation and UNAIDS, the Wall Street Journal reports. "All told, governments donated about $6.9 billion in 2010, down 9.7 percent from about $7.6 billion in the prior year, the report said," the newspaper writes.

17 Aug 2011

Experts fear shrinking DOD budget, shifting AFRICOM focus could threaten HIV prevention programs

A shrinking Department of Defense (DOD) budget and a shift in the focus of the U.S. Africa Command (AFRICOM) to "more traditional military threats" to national security, such as "preventing terrorist safe havens on the continent," could affect the department's HIV prevention programs, Stars and Stripes reports.

17 Aug 2011

Inexpensive microcalorimeters can quickly detect TB

Researchers have discovered a faster, cheaper method for the diagnosis of tuberculosis (TB). A major barrier in TB prevention, especially in developing countries, is that diagnosis is slow and costly.

17 Aug 2011

Study finds broadest immune response from LAIV nasal spray vaccines for children

Children younger than 3 years old receive the same protective antibody response from the recommended two doses of licensed seasonal influenza vaccines regardless of whether the two doses are injected by needle, inhaled through a nasal spray or provided through one dose of each in any order, according to researchers funded by the National Institutes of Health.

17 Aug 2011

Curis initiates CUDC-101 Phase I combination trial in advanced head and neck cancer

Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today announced that the first patient has been treated in a Phase I combination trial of CUDC-101.

17 Aug 2011

Disease outbreaks, looting hampering relief efforts in Somalia famine

"Outbreaks of measles and cholera are striking down Somali children already weakened by hunger, resulting in dozens of new fatalities," the Guardian reports (Rice, 8/13).

16 Aug 2011

Nearly 6,000 dead in Haitian cholera outbreak, health ministry says

"The number of cholera fatalities in Haiti has risen to just short of 6,000, the health ministry said Sunday," Deutsche Presse-Agentur/M&C reports.

16 Aug 2011

Zinc lozenges might reduce duration of common cold episodes by 40%

Depending on the total dosage of zinc and the composition of lozenges, zinc lozenges may shorten the duration of common cold episodes by up to 40%, says Dr. Harri Hemila from the University of Helsinki.

16 Aug 2011

South Africa expands AIDS program to allow earlier ARV treatment

The South African National AIDS Council (SANAC) on Saturday endorsed a new National Health Council policy to expand the country's AIDS program "to allow people living with HIV to start antiretroviral [ARV] treatment earlier" by raising the CD4 count necessary to access treatment from 200 to 350, Agence France-Presse reports.

16 Aug 2011